Cargando…
Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice
BACKGROUND: Hepatoprotective effects of Chinese herbal medicine Schisandra Chinensis (Schisandra) have been widely investigated. However, most studies were focused on its lignan extracts. We investigated the effects of Schisandra polysaccharide (SCP) in a mouse model of non-alcoholic fatty liver dis...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112637/ https://www.ncbi.nlm.nih.gov/pubmed/27852305 http://dx.doi.org/10.1186/s12944-016-0358-5 |
_version_ | 1782468041334849536 |
---|---|
author | Wang, Chun-Mei Yuan, Rong-Shuang Zhuang, Wen-Yue Sun, Jing-Hui Wu, Jin-Ying Li, He Chen, Jian-Guang |
author_facet | Wang, Chun-Mei Yuan, Rong-Shuang Zhuang, Wen-Yue Sun, Jing-Hui Wu, Jin-Ying Li, He Chen, Jian-Guang |
author_sort | Wang, Chun-Mei |
collection | PubMed |
description | BACKGROUND: Hepatoprotective effects of Chinese herbal medicine Schisandra Chinensis (Schisandra) have been widely investigated. However, most studies were focused on its lignan extracts. We investigated the effects of Schisandra polysaccharide (SCP) in a mouse model of non-alcoholic fatty liver disease (NAFLD), and studied its effect on sterol regulatory element binding proteins (SREBPs) and the related genes. METHODS: The mouse model of NAFLD was established by feeding mice with a high-fat diet for 16 weeks. Effect of SCP-treatment (100 mg/kg, once daily for 12 weeks) on biochemical parameters and liver histopathology was assessed. Relative levels of sterol regulatory element-binding proteins (SREBPs) and their gene expressions were determined by quantitative real-time polymerase chain reaction and Western Blot. RESULTS: SCP significantly reduced the liver index by 12.0%. Serum levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol, alanine aminotransferase and aspartate aminotransferase were decreased by 31.3, 28.3, 42.8, 20.1 and 15.5%, respectively. Serum high-density lipoprotein cholesterol was increased by 26.9%. Further, SCP lowered hepatic TC and TG content by 27.0% and 28.3%, respectively, and alleviated fatty degeneration and necrosis of liver cells. A significant downregulation of mRNA and protein expressions of hepatic lipogenesis genes, SREBP-1c, fatty acid synthase and acetyl-CoA carboxylase, and the mRNA expression of liver X receptor α (LXRα) was observed in NAFLD mice treated with SCP. SCP also significantly reduced the hepatic expression of SREBP-2 and 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR). CONCLUSION: These findings demonstrate the hepatoprotective effects of SCP in a mouse model of NAFLD; the effects may be mediated via downregulation of LXRα/SREBP-1c/FAS/ACC and SREBP-2/HMGCR signaling pathways in the liver. |
format | Online Article Text |
id | pubmed-5112637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51126372016-11-25 Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice Wang, Chun-Mei Yuan, Rong-Shuang Zhuang, Wen-Yue Sun, Jing-Hui Wu, Jin-Ying Li, He Chen, Jian-Guang Lipids Health Dis Research BACKGROUND: Hepatoprotective effects of Chinese herbal medicine Schisandra Chinensis (Schisandra) have been widely investigated. However, most studies were focused on its lignan extracts. We investigated the effects of Schisandra polysaccharide (SCP) in a mouse model of non-alcoholic fatty liver disease (NAFLD), and studied its effect on sterol regulatory element binding proteins (SREBPs) and the related genes. METHODS: The mouse model of NAFLD was established by feeding mice with a high-fat diet for 16 weeks. Effect of SCP-treatment (100 mg/kg, once daily for 12 weeks) on biochemical parameters and liver histopathology was assessed. Relative levels of sterol regulatory element-binding proteins (SREBPs) and their gene expressions were determined by quantitative real-time polymerase chain reaction and Western Blot. RESULTS: SCP significantly reduced the liver index by 12.0%. Serum levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol, alanine aminotransferase and aspartate aminotransferase were decreased by 31.3, 28.3, 42.8, 20.1 and 15.5%, respectively. Serum high-density lipoprotein cholesterol was increased by 26.9%. Further, SCP lowered hepatic TC and TG content by 27.0% and 28.3%, respectively, and alleviated fatty degeneration and necrosis of liver cells. A significant downregulation of mRNA and protein expressions of hepatic lipogenesis genes, SREBP-1c, fatty acid synthase and acetyl-CoA carboxylase, and the mRNA expression of liver X receptor α (LXRα) was observed in NAFLD mice treated with SCP. SCP also significantly reduced the hepatic expression of SREBP-2 and 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR). CONCLUSION: These findings demonstrate the hepatoprotective effects of SCP in a mouse model of NAFLD; the effects may be mediated via downregulation of LXRα/SREBP-1c/FAS/ACC and SREBP-2/HMGCR signaling pathways in the liver. BioMed Central 2016-11-16 /pmc/articles/PMC5112637/ /pubmed/27852305 http://dx.doi.org/10.1186/s12944-016-0358-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Wang, Chun-Mei Yuan, Rong-Shuang Zhuang, Wen-Yue Sun, Jing-Hui Wu, Jin-Ying Li, He Chen, Jian-Guang Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice |
title | Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice |
title_full | Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice |
title_fullStr | Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice |
title_full_unstemmed | Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice |
title_short | Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice |
title_sort | schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of srebps in nafld mice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112637/ https://www.ncbi.nlm.nih.gov/pubmed/27852305 http://dx.doi.org/10.1186/s12944-016-0358-5 |
work_keys_str_mv | AT wangchunmei schisandrapolysaccharideinhibitshepaticlipidaccumulationbydownregulatingexpressionofsrebpsinnafldmice AT yuanrongshuang schisandrapolysaccharideinhibitshepaticlipidaccumulationbydownregulatingexpressionofsrebpsinnafldmice AT zhuangwenyue schisandrapolysaccharideinhibitshepaticlipidaccumulationbydownregulatingexpressionofsrebpsinnafldmice AT sunjinghui schisandrapolysaccharideinhibitshepaticlipidaccumulationbydownregulatingexpressionofsrebpsinnafldmice AT wujinying schisandrapolysaccharideinhibitshepaticlipidaccumulationbydownregulatingexpressionofsrebpsinnafldmice AT lihe schisandrapolysaccharideinhibitshepaticlipidaccumulationbydownregulatingexpressionofsrebpsinnafldmice AT chenjianguang schisandrapolysaccharideinhibitshepaticlipidaccumulationbydownregulatingexpressionofsrebpsinnafldmice |